Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when TOI files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: TOI Starling Oncology, Inc. 8-K

Oncology Institute reports Q1 2026 financial results

Filed May 7, 2026 · Period ending May 7, 2026 · ~1 min read

1 key change 1 high relevance 2 sections

Key Changes

  • high

    Company announced first quarter 2026 earnings via press release on May 7, 2026. Actual financial figures are contained in the attached exhibit rather than the 8-K body itself.

Summary

The Oncology Institute filed an 8-K to announce its first quarter 2026 financial results through an attached press release dated May 7, 2026. This is a standard quarterly earnings disclosure, with the actual revenue, earnings, and other financial metrics provided in the press release exhibit rather than in the body of the 8-K filing itself.

For retail investors, the key takeaway is that Q1 results are now public, though you'll need to review the attached press release (Exhibit 99.1) to see the actual numbers and management commentary. Watch for any guidance updates or operational metrics in the press release that might signal changes in the company's oncology practice performance or patient volume trends.

Section-by-Section Diff

Event · Item 2.02 — Results of Operations and Financial Condition

~100 words

Company announced Q1 2026 financial results via press release.

1 Added
Added Q1 2026 earnings announcement high

Added in current filing · verify on EDGAR →

On May 7, 2026, The Oncology Institute, Inc. (the "Company") issued a press release announcing its financial results for the three months ended March 31, 2026 and certain other financial information.

The Company disclosed its first quarter 2026 financial results through a press release. The 8-K itself does not contain the actual financial figures, which are provided in the attached press release exhibit. This is a standard earnings announcement filing.

Event · Item 9.01 — Financial Statements and Exhibits

~100 words

The Oncology Institute filed an 8-K attaching a press release issued May 7, 2026; no material event details disclosed in filing body.

1 Added
Show 1 minor / wording change
Added Press release attachment low

Added in current filing · verify on EDGAR →

Press Release issued by The Oncology Institute, Inc. on May 7, 2026

The company attached a press release dated May 7, 2026 as Exhibit 99.1. The 8-K body does not describe the content of the press release, so the nature of the disclosed event cannot be determined from this filing alone.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify